Immunic (IMUX) announced that IMU-856, an orally available and systemically acting small molecule modulator that targets SIRT6, demonstrated a ...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.

The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the ...

Here we highlight a subset of our preferred stocks from the screener. Overview: Articore Group Limited operates as an online marketplace for art and design products across Australia, the United States ...

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Australian shares are set to rise, after tariff turbulence eased on Wall Street, while the local currency climbed back towards 63 US cents. Shares in Google parent company Alphabet fell on its ...

Article Page URL has been copied to clipboard for sharing. Mentioned: Auckland International Airport Ltd (AIA) In the prior edition of this article I explored Auckland International Airport (ASX: AIA) ...

Learn More S&P/ASX 200 Index (ASX: XJO) stocks are trading just inside the green at 8,419.7 points in late afternoon trade on Tuesday. The ASX 200 dipped then flipped in early trading after a sell ...

Chinese AI company DeepSeek has developed a AI model far cheaper than its US peers, sparking concerns for Nvidia and tech stocks ASX tech stocks fell sharply on Tuesday, with data centre names like ...

The new and apparently lower-cost player from China saw America’s big tech stocks hammered on Wall Street overnight, which trickled down to local ASX-listed tech companies and real estate ...

With local heavyweights like Macquarie, Pro Medicus, Cochlear, CSL, and REA Group all trading above $200, what’s stopping them (or another ASX company) from hitting $500 from their current price? To ...